Originally published In Press as doi:10.1074/jbc.M112377200 on March 20, 2002
J. Biol. Chem., Vol. 277, Issue 22, 19255-19264, May 31, 2002
Overexpression of Calreticulin Modulates Protein Kinase B/Akt
Signaling to Promote Apoptosis during Cardiac Differentiation of
Cardiomyoblast H9c2 Cells*
Kan
Kageyama
§¶,
Yoshito
Ihara
¶
,
Shinji
Goto
,
Yoshishige
Urata
,
Genji
Toda§,
Katsusuke
Yano§, and
Takahito
Kondo
From the
Department of Biochemistry and
Molecular Biology in Disease, Atomic Bomb Disease Institute, and the
§ Third Department of Internal Medicine, Nagasaki University
School of Medicine, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
Received for publication, December 26, 2001, and in revised form, March 11, 2002
 |
ABSTRACT |
Calreticulin is a Ca2+-binding
molecular chaperone of the lumen of the endoplasmic reticulum.
Calreticulin has been shown to be essential for cardiac and neural
development in mice, but the mechanism by which it functions in cell
differentiation is not fully understood. To examine the role of
calreticulin in cardiac differentiation, the calreticulin gene was
introduced into rat cardiomyoblast H9c2 cells, and the effect of
calreticulin overexpression on cardiac differentiation was examined.
Upon culture in a differentiation medium containing fetal calf serum
(1%) and retinoic acid (10 nM), cells transfected with the
calreticulin gene were highly susceptible to apoptosis compared with
controls. In the gene-transfected cells, protein kinase B/Akt signaling
was significantly suppressed during differentiation. Furthermore,
protein phosphatase 2A, a Ser/Thr protein phosphatase, was
significantly up-regulated, implying suppression of Akt signaling due
to dephosphorylation of Akt by the up-regulated protein phosphatase 2A
via regulation of Ca2+ homeostasis. Thus, overexpression of
calreticulin promotes differentiation-dependent apoptosis in H9c2 cells by suppressing the Akt signaling pathway. These findings indicate a novel mechanism by which cytoplasmic Akt
signaling is modulated to cause apoptosis by a resident protein of the
endoplasmic reticulum, calreticulin.
 |
INTRODUCTION |
Calreticulin (CRT)1 is a
Ca2+-binding molecular chaperone in the endoplasmic
reticulum (ER) (1). It is a highly conserved protein with >90% amino
acid identity in mammals, including human, rabbit, rat, and mouse (2).
The gene has also been found in insects, nematodes, protozoa, and
plants, but not in yeast or prokaryotes (1, 3), suggesting a general
function in living cells. CRT is involved in many biological
process, including regulation of Ca2+ homeostasis and
intracellular signaling, cell adhesion, gene expression, and
glycoprotein folding (3, 4) and nuclear transport (5).
CRT is well expressed in embryonic rat heart, but its expression is
significantly suppressed after birth (6). Cardiac development is
believed to be regulated cooperatively by a variety of proteins, including signaling molecules (e.g. fibroblast growth
factor, transforming growth factor-
, ErbB2/B4, neuregulin, etc.),
cell adhesion molecules (e.g. vascular cell adhesion
molecule,
4 integrin, and versican), ion
channels, and transcription factors (e.g. GATA, myocyte
enhancer factor-2, HAND, chicken ovalbumin upstream promoter transcription factor II, Nkx2.5, TBX5, NF-ATc, Smad6, Pax3,
retinoid X receptor/retinoic acid receptor, TEF-1, WT-1,
etc.) (7). Interestingly, CRT gene expression is known to be regulated
by a transcription factor (Nkx2.5) that is involved in the regulation of gene expression for cardiac development (8). Recently, it has been
shown that CRT is essential for cardiac and neural development in mice
(9, 10). CRT-deficient embryonic cells show impaired nuclear import of
the transcription factor NF-AT3 (nuclear factor of activated T cells), indicating that CRT
functions in cardiac development as a component of the
Ca2+/calcineurin/NF-AT/GATA-4 transcription pathway (9).
Very recently, it has also been reported that CRT transgenic mice
suffer complete heart block and sudden death (11). In that study, it
was described that CRT-dependent cardiac block involves
impairment of both the L-type Ca2+ channel and gap junction
connexin-40 and connexin-43. Also observed was a decrease in
phosphorylated connexin-43 in CRT transgenic heart, suggesting that the
functions of protein kinases are altered via the regulation of
Ca2+ homeostasis. The study indicates that overexpression
of CRT affects not the morphogenesis, but the physiological function of
cardiomyoblasts. The overall mechanism of the dephosphorylation of
connexin-43 in CRT transgenic heart cells is not known, but may involve
the altered regulation of protein kinase pathways. These studies
suggest that CRT plays a vital role in cardiac differentiation and
function, although how has not been fully clarified.
In this study, we investigated the biological role of CRT using rat
cardiomyoblast H9c2 cells transfected with the CRT gene. We show that
overexpression of CRT promotes apoptosis during cardiac differentiation
and that suppression of protein kinase B/Akt signaling for cell
survival is involved in the apoptotic process. We also show that
expression of protein phosphatase 2A (PP2A), a Ser/Thr protein
phosphatase, is involved in altering the regulation of Akt signaling in
H9c2 cells overexpressing CRT via the regulation of Ca2+ homeostasis.
 |
MATERIALS AND METHODS |
Antibodies and Reagents--
Antibodies against CRT,
calnexin, and Grp78/BiP were purchased from Stressgen Biotech Corp.
(Victoria, British Columbia, Canada). The antibody against the protein
phosphatase 1
(PP1
) catalytic subunit (PP1
c) was obtained from
Santa Cruz Biotechnology (Santa Cruz, CA). The anti-Akt and
anti-phosphorylated Akt (Ser473) antibodies were purchased
from Cell Signaling Technology (Beverly, MA). Antibodies against
PP2B-A
(calcineurin) and PP2C
were from Upstate Biotechnology,
Inc. (Lake Placid, NY). The anti-PP2A catalytic subunit
(PP2Ac
)
antibody was from Transduction Laboratories (Lexington, KY). The
reagents used in the study were all high grade and were from Sigma or
Wako Pure Chemicals (Osaka, Japan).
Cell Culture--
H9c2 cells, a clonal line derived from
embryonic rat heart (12, 13), were obtained from American Type Culture
Collection (CRL-1446). H9c2 cells and the CRT gene-transfected cells
were cultured in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal calf serum (FCS) in a humidified
atmosphere of 95% air and 5% CO2 at 37 °C. Before
reaching confluence, the cells were split, plated at low density in
culture dishes containing 10% FCS culture medium, and cultured for
24 h. To induce cardiac differentiation, cells were then cultured
in DMEM supplemented with 1% FCS and 10 nM
all-trans-retinoic acid (RA) according to the method
described by Ménard et al. (14). The culture medium was replaced every 2 days.
Construction of a CRT Gene Expression Vector--
A full-length
mouse CRT cDNA was cloned from total RNA of mouse monocyte-derived
leukemia RAW264.7 cells by reverse transcription-PCR using SuperScript
II RNase H reverse transcriptase (Invitrogen) and Advantage-HF2
Taq polymerase (CLONTECH, Palo Alto, CA)
with the following primer pair, which was designed on the basis of reported nucleotide sequences (15): Primer S, CCATGCTCCTTTCGGTGCCG; and
Primer A, GTGGCCTCTACAGCTCATCC. The amplified DNA fragments were
subcloned into a TA cloning vector (pCRII, Invitrogen), and the
nucleotide sequences of the PCR product were confirmed by sequencing
with an ALFexpress II system (Amersham Biosciences, Buckinghamshire,
UK). The CRT cDNA was cloned into plasmid pcDNA3.1 (Invitrogen)
under the control of the cytomegalovirus promoter for expression in
mammalian cells.
Gene Transfection and Selection of Cells--
The mock and CRT
gene expression vectors were transfected into H9c2 cells using
LipofectAMINE Plus reagent (Invitrogen) according to the
manufacturer's protocol. Stable transfectants were screened by
culturing with 500 µg/ml G418. The cloned G418-resistant lines were
then screened for expression of CRT. Two cell lines (CRT-S2 and CRT-S8)
found to express high levels of CRT upon immunoblot analysis (see Fig.
1A) were selected and used for the experiments.
Fluorescence Microscopy--
Cells (5 × 104/ml) were grown on Lab-Tek chamber slides for 24 h.
They were fixed with 4% paraformaldehyde in phosphate-buffered saline
(PBS; pH 7.2) and permeabilized for 10 min with PBS containing 0.1%
Triton X-100. The cells were then blocked with 1% bovine serum albumin
in PBS, incubated with anti-CRT or anti-calnexin antibody for 1 h,
and washed with PBS containing 1% bovine serum albumin. The
immunoreactive primary antibody was visualized with fluorescein
isothiocyanate-conjugated anti-rabbit immunoglobulin (Cappel). After
washing, the stained cells were mounted in Vectashield medium. A Zeiss
Axioskop2 (Carl Zeiss, Jena, Germany) with epi-illumination for
fluorescence was used for fluorescence microscopic analysis.
Cell Proliferation Assay--
The proliferation of cultured
cells was evaluated by measuring attached live cells photometrically
after staining with crystal violet. The cells (3000) were placed
in 100 µl of medium/well in 96-well plates and cultured with or
without the differentiation treatment. After a specific period, the
cells were fixed with 4% paraformaldehyde in PBS, washed, and stained
with 0.01% crystal violet at room temperature for 20 min. Each well
was extensively washed with water and dried. The stained cells were
lysed by adding 100 µl of lysis buffer (20% SDS and 50%
N,N-dimethylformamide (pH 4.7)), and the cell
number was then estimated by measuring the absorbance at 570 nm using a
microplate reader.
Apoptosis Assay--
Apoptosis was detected by flow cytometry
with the terminal deoxynucleotidyltransferase-mediated dUTP nick end
labeling (TUNEL) method (16) using an ApopTag Plus fluorescein in
situ apoptosis detection kit (Intergen Co., Purchase, NY).
Briefly, cells were harvested and fixed in 70% ethanol, treated with
terminal deoxynucleotidyltransferase for 1 h and then with
fluorescein isothiocyanate-conjugated anti-digoxigenin antibody
for 1 h at room temperature, and washed with PBS containing 0.1%
Triton X-100. Fluorescence intensity was measured at 530 nm using a
flow cytometer (BD PharMingen). Apoptosis was also measured by
flow cytometry as described (17). Briefly, the cells were washed with
PBS and resuspended in PBS with 0.1% Triton X-100 and 50 µg/ml
propidium iodide. The DNA content was analyzed by flow cytometry.
Hypodiploid cells containing a smaller amount of DNA and a side scatter
higher than that of G0/G1 cells were considered
to be apoptotic. Caspase-3 activity was assayed by spectrophotometric
detection of the chromophore p-nitroanilide after cleavage
from the substrate DEVD-p-nitroanilide using a CPP32/caspase-3 colorimetric protease assay kit (Medical & Biological Laboratories, Nagoya, Japan). The p-nitroanilide light
emission was quantified by measuring the absorbance at 405 nm.
Immunoblot Analysis--
Cultured cells were harvested and lysed
for 20 min at 4 °C in lysis buffer (20 mM Tris-HCl (pH
7.5), 130 mM NaCl, 1% Nonidet P-40, 10% glycerol, 0.4 mM sodium orthovanadate, 10 mM sodium pyrophosphate, and 10 mM sodium fluoride including protease
inhibitors (20 µM amidinophenyl methanesulfonyl fluoride,
50 µM pepstatin, and 50 µM leupeptin)). The
supernatants obtained on centrifugation at 8,000 × g for 10 min then were used in subsequent experiments. Protein samples were
electrophoresed on 7.5, 10, or 12.5% SDS-polyacrylamide gels under
reducing conditions and then transferred to nitrocellulose membrane as
described (18). The membrane was blocked with 3% bovine serum albumin
or 5% skim milk in Tris-buffered saline (10 mM Tris-HCl
(pH 7.5) and 0.15 M NaCl) and incubated at room temperature for 2 h with the primary antibody in Tris-buffered saline
containing 0.05% Tween 20. The blots were coupled with the
peroxidase-conjugated secondary antibodies, washed, and then developed
using the ECL chemiluminescence detection kit (Amersham Biosciences)
according to the manufacturer's instructions.
Akt Activity Assay--
Akt activity was assayed using an
Akt assay kit (Cell Signaling Technology) according to the
manufacturer's protocol. Briefly, Akt was immunoprecipitated from cell
lysates using anti-Akt antibody, and the immunoprecipitates were then
incubated at 30 °C for 30 min in an assay mixture containing an Akt
substrate, GSK-3
/
fusion protein. Phosphorylated proteins were
separated by 12.5% SDS-PAGE and then transferred to nitrocellulose
membrane to detect phosphorylated GSK-3
/
using
anti-phosphorylated GSK-3
/
(Ser21/9) antibody.
Northern Blot Analysis--
The full-length rat PP1
c and
PP2Ac
cDNAs were generously provided by Dr. Kunimi Kikuchi
(Hokkaido University, Hokkaido, Japan) (19, 20). A
PstI-SmaI fragment of 600 bp and an
EcoRI-PvuII fragment of 680 bp were prepared from
the cDNAs of PP1
c and PP2Ac
, respectively, and used as
cDNA probes. The probes were radiolabeled with 32P
using a random primer labeling kit (Takara Biomedicals, Shiga, Japan).
The isolation of cytoplasmic RNA and Northern blotting were essentially
performed as described by Sambrook et al. (21). Isolated
RNAs (10 µg) were electrophoresed on a 1% agarose gel containing 0.6 M formaldehyde, transferred to a nylon membrane, and then
hybridized with 32P-labeled probes. Autoradiographed
membranes were analyzed using a BAS5000 bioimage analyzer (Fuji Photo Film).
Protein Phosphatase Assay--
Ser/Thr protein phosphatase
activity was assayed photometrically using a Ser/Thr phosphatase assay
kit (kit 1, Upstate Biotechnology, Inc.) according to the
manufacturer's protocol. The phosphopeptide RKpTIRR and
p-nitrophenyl phosphate were used as phosphatase substrates. Protein concentrations were determined using a BCA assay kit (Pierce).
Measurement of Intracellular Free Calcium--
The intracellular
free calcium concentration was measured using fura-2 essentially as
described previously (22). Briefly, cells cultured on glass coverslips
were loaded with 5 µM fura-2/AM (Dojindo, Kumamoto,
Japan) for 20 min in Earle's balanced salt solution in the presence of
0.01% pluronic F-127. After four washes with Earle's balanced salt
solution, the coverslip was positioned in a quartz cuvette
containing 3.5 ml of fresh Earle's balanced salt solution at a 45°
angle to both the excitation and emission light paths. The fura-2
fluorescence was determined at 37 °C using a Shimadzu RF-5000
spectrofluorophotometer operating at an emission wavelength of 505 nm
with excitation wavelengths of 340 and 380 nm. The maximal signal
(Rmax) was obtained by adding ionomycin at a
final concentration of 4 µM. Then, the minimal signal
(Rmin) was obtained by adding EGTA at a final
concentration of 7.5 mM, followed by Tris-free base at a
final concentration of 30 mM, to increase the pH to 8.3. R is the ratio (F1/F2) of the fluorescence of
Ex340 nm/Em505 nm (F1) to that of
Ex380 nm/Em505 nm (F2). The actual calcium
concentration was calculated as Kd × (R
Rmin)/(Rmax
R), with Kd equal to 224 nM
(23).
 |
RESULTS |
Establishment of CRT Gene Overexpressers Using H9c2 Cells--
To
investigate the functional roles of CRT during cardiac differentiation,
a CRT gene expression vector was constructed and transfected into rat
cardiomyoblast H9c2 cells. After the screening of G418-resistant
transfectants, the expression level of CRT was characterized
immunologically. Two high expression transfectants (CRT-S2 and CRT-S8)
were used in subsequent experiments. Fig. 1A shows that expression of
CRT increased in the overexpressers to ~2.7-fold the level in the
parental and mock-transfected (control) H9c2 cells. Transfection had no
apparent effect on expression of other ER chaperones such as calnexin
and BiP. The intracellular localization of CRT was examined by indirect
immunofluorescence. As shown in Fig. 1B, immunoreactive
signals showed a perinuclear reticular pattern in all cases, including
the control and gene-transfected cells, although the signal intensity
was increased in the transfectants compared with the control cells.
Under non-permeabilized conditions, no significant increase in CRT
expression on the cell surface was observed in the gene-transfected
cells (data not shown). In the case of calnexin, the transfectants were
similar to controls in the localization and intensity of immunoreactive
signals.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 1.
A, calreticulin expression in control
and CRT gene-transfected H9c2 cells. The expression levels for CRT,
calnexin (CNX), and BiP were estimated by immunoblot
analysis using specific antibodies as described under "Materials and
Methods." The data represent three independent experiments.
B, intracellular localization of CRT and calnexin in control
and transfected H9c2 cells. The intracellular localization of CRT and
calnexin was evaluated by indirect immunofluorescence (IF)
microscopy using specific antibodies. The data represent two
independent experiments.
|
|
Effect of Overexpression of CRT on the Differentiation of H9c2
Cells--
The H9c2 cell acquires the cardiac phenotype under
conditions of retinoic acid-induced differentiation (14). To test the effect of overexpressed CRT on cardiac differentiation, control and
gene-transfected H9c2 cells were cultured with or without differentiation medium (1% FCS and 10 nM RA in DMEM), and
cell proliferation and morphology were compared. As shown in Fig.
2A, after 5 days of culture in
differentiation medium, cell proliferation was suppressed in control
cells, but was only reduced in the transfectants. Cardiac
differentiation was confirmed as described by Ménard et
al. (14) by suppression of cell proliferation and increase in
expression of specific differentiation markers such as L-type voltage-dependent calcium channel
1C and myosin heavy
chain by immunoblot analysis (data not shown). Under normal culture
conditions, cell proliferation in the gene transfectants was relatively
reduced compared with the control cells. Fig. 2B shows that
after 5 days of culture in differentiation medium, large and round
differentiated cells were seen in the control cultures. The results are
consistent with a previous report (14). In contrast, the transfectants were small and round and mostly detached from the plastic culture dish,
suggesting they had been damaged by the treatment.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 2.
A, proliferation of control and
gene-transfected H9c2 cells treated with differentiation medium for 5 days. Cell proliferation was evaluated by measuring attached live cells
photometrically after staining with crystal violet as described under
"Materials and Methods." Each value represents the mean of four
independent experiments, and the S.D. was always within 10% of the
mean. B, morphological change in control and
gene-transfected H9c2 cells during differentiation. The cells were
cultured in differentiation medium for 5 days, and cell morphology was
characterized microscopically. The results were reproducible in five
independent experiments.
|
|
Overexpression of CRT Causes Apoptosis during the Cardiac
Differentiation of H9c2 Cells--
To examine whether apoptosis
contributed to the cell damage seen in the transfectants after the
differentiation treatment, a TUNEL assay and analysis of DNA content
with propidium iodide staining were carried out using cells treated
with or without differentiation medium for 3 days. In the TUNEL assay
(Fig. 3A), an increase in
fluorescence intensity derived from DNA strand breaks was detected in
the transfectants, but not in the control cells cultured in
differentiation medium. Upon staining with propidium iodide (Fig.
3B), apoptotic cells appeared as a hypodiploid DNA peak
preceding the narrow peak of diploid DNA from viable cells. In the
transfectants, a hypodiploid DNA peak was detected after differentiation treatment. No such peak was seen in control cells. Next, the activity of caspase-3 was examined in the cells cultured with
or without differentiation medium for 3 days. Caspase-3 activity was
markedly elevated after the differentiation treatment in the transfectants compared with the control cells (Fig. 3C).
These results indicate that apoptosis was promoted by overexpression of
CRT in H9c2 cells during the experimentally induced
differentiation.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
A, TUNEL assay for control and
gene-transfected H9c2 cells upon differentiation treatment. DNA
double-strand breaks were detected by the TUNEL method as described
under "Materials and Methods." Cells were treated with (thick
lines) or without (thin lines) differentiation medium
for 3 days. The data represent three independent experiments.
B, flow cytometric analysis of DNA content in control and
gene-transfected H9c2 cells upon differentiation treatment. Cells were
treated with (thick lines) or without (thin
lines) differentiation medium for 3 days. The data represent four
independent experiments. C, caspase-3 activity in control
and gene-transfected H9c2 cells upon differentiation treatment for 3 days. Caspase-3 activity was assayed photometrically as described under
"Materials and Methods" using DEVD-p-nitroanilide as a
substrate. Each value represents the mean ± S.D. of four
independent experiments.
|
|
Overexpression of CRT Suppresses Protein Kinase B/Akt Activity
during the Cardiac Differentiation of H9c2 Cells--
Apoptosis
is known to be regulated by several signal transduction pathways,
including the stress-activated protein kinase (SAPK), mitogen-activated
protein kinase (MAPK), and protein kinase B/Akt pathways (24). To
reveal whether overexpression of CRT affected the cell survival
signaling of Akt during differentiation-induced apoptosis, the
phosphorylation of Akt Ser473 was examined and compared
between control cells and cells transfected with the CRT gene during
differentiation (Fig. 4A). In
controls, the levels of Ser473-phosphorylated Akt were
unchanged on day 1 of the differentiation treatment, but decreased to
37% of initial values on day 3. In contrast, in the transfectants,
they decreased to 35% of the initial level on day 1 of treatment. Akt
activity was also examined in the controls and transfectants after
24 h of treatment to induce differentiation. Fig. 4B
shows that Akt activity was suppressed after 24 h of culture in
differentiation medium in the transfectants, but not in the control
cells. This is consistent with the finding that the level of
phosphorylated Akt correlates well with the activity of Akt (25). The
phosphorylation of BAD, a downstream signal of Akt, was examined.
Despite the change in Akt activity, the level of phosphorylated BAD did
not change significantly in either the control or transfected cells
during differentiation (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
A, phosphorylation of Akt in control and
gene-transfected H9c2 cells upon differentiation treatment for 3 days.
Ser473-phosphorylated Akt and total Akt were detected by
immunoblot (IB) analysis using specific antibodies as
described under "Materials and Methods." The band intensity was
estimated densitometrically, and the phosphorylation rate is expressed
as the relative intensity of phosphorylated Akt (Akt-P)/Akt.
Each value represents the mean ± S.D. of four independent
experiments. B, Akt activity in control and gene-transfected
H9c2 cells upon differentiation treatment for 24 h. Akt activity
was assayed as described under "Materials and Methods." Akt was
immunoprecipitated from cell lysates (500 µg) using anti-Akt
antibody, and Akt activity was then measured using GSK-3 / as a
substrate. Phosphorylated GSK-3 / was detected by immunoblot
analysis using anti-phosphorylated GSK-3 / antibody
(Anti-GSK3- / -P). The data represent three independent
experiments.
|
|
Differentiation Treatment-induced Apoptosis Is Enhanced in the
Presence of Wortmannin and LY294002 in Both Control and CRT
Gene-transfected H9c2 Cells--
To clarify the significance of Akt
signaling to anti-apoptotic functions, cells were treated with 1% FCS
and RA for 24 h in the presence or absence of the
phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin (300 nM) and LY294002 (10 µM), and
apoptosis was then examined by TUNEL methods. Fig.
5A shows that the PI3K inhibitors enhanced apoptosis during treatment for 24 h in both control and transfected cells. Caspase-3 activity was also induced by
the inhibitors (data not shown). Moreover, Fig. 5B shows
that phosphorylation of Akt was suppressed by the PI3K inhibitors
during treatment. Thus, suppression of Akt signaling by specific
inhibitors enhanced the differentiation-induced apoptosis, suggesting
that Akt signaling has a vital anti-apoptotic function in this
differentiation model.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of wortmannin and LY294002 on
apoptosis and phosphorylation of Akt in control and gene-transfected
H9c2 cells upon differentiation treatment. A, TUNEL
assay for control and transfected H9c2 cells upon differentiation
treatment with or without wortmannin (300 nM) or LY294002
(10 µM) for 24 h. The number of apoptotic cells is
expressed as a shift of the mean intensity in TUNEL-positive cells.
Each value represents the mean ± S.D. of three independent
experiments. B, phosphorylation of Akt in control and
gene-transfected H9c2 cells upon differentiation treatment with or
without wortmannin or LY294002 as described for A.
Ser473-phosphorylated Akt (Akt-P) and total Akt
were detected by immunoblot (IB) analysis using specific
antibodies as described under "Materials and Methods." The data
represent three independent experiments.
|
|
Protein Phosphatase 2A Is Up-regulated in H9c2 Cells Transfected
with the CRT Gene--
To establish whether overexpression of CRT
affects the activity of PI3K, an upstream signaling molecule of Akt, we
examined PI3K activity in control and gene-transfected cells treated
with or without differentiation medium for 24 h. However, PI3K
activity was not affected by overexpression of CRT during
differentiation (data not shown). Next, to identify the molecules that
suppressed Akt signaling in the transfectants upon the differentiation
treatment, we focused on Ser/Thr phosphatases that could
dephosphorylate Akt to suppress the signaling. Fig.
6A shows the protein levels for cytosolic Ser/Thr phosphatases (i.e. PP1
c, PP2Ac
,
PP2B-A
, and PP2C
) determined by immunoblot analysis in control
and gene-transfected cells with or without the differentiation
treatment (1% FCS and RA for 24 h). In the case of both PP1
c
and PP2B-A
(calcineurin), there was no significant difference in the
level of expression between the control and transfected cells, although
the level increased slightly after the differentiation treatment. In
contrast, the protein levels of PP2Ac
increased significantly in the
transfectants compared with the controls and increased during
differentiation in both cases. Interestingly, for PP2C
, protein
levels were relatively suppressed in the transfectants. Moreover, no
differentiation-induced increase in expression was observed, unlike for
PP2Ac
. The mRNA expression levels for PP2Ac
and PP1
c were
examined by Northern blot analysis (Fig. 6B). The mRNA
for PP2Ac
increased significantly in the transfectants compared with
the controls and following differentiation treatment in both cases. No
such elevation in the basal level of mRNA was seen in the case of
PP1
c. These results are consistent with the protein expression
levels shown in Fig. 6A.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Protein phosphatase 2A is up-regulated in
gene-transfected H9c2 cells. A, immunoblot analysis of
Ser/Thr protein phosphatases in control and gene-transfected H9c2 cells
upon differentiation treatment for 24 h. The protein expression
levels for cytoplasmic Ser/Thr protein phosphatases, including PP1 c, PP2Ac ,
PP2B-A (calcineurin), and PP2C , were estimated by immunoblot
(IB) analysis using specific antibodies as described under
"Materials and Methods." B, Northern blot analysis of
PP2Ac and PP1 c in control and gene-transfected H9c2 cells upon
differentiation treatment for 24 h. Total RNA (10 µg) was
separated by electrophoresis on 1% agarose gel containing
formaldehyde. After blotting onto nylon membrane, the membrane filter
was hybridized with 32P-labeled DNA probes for PP1 c and
PP2Ac . Autoradiographed membranes were analyzed using a Fuji BAS5000
bioimage analyzer. C, enzymatic activities of PP2A and total
phosphatase in control and gene-transfected H9c2 cells upon
differentiation treatment for 24 h. The activities of total
phosphatase and PP2A were assayed photometrically as described under
"Materials and Methods" using p-nitrophenyl phosphate
and RKpTIRR, respectively. Each value represents the mean ± S.D.
of three independent experiments.
|
|
Next, we examined the enzymatic activity of total phosphatase and PP2A.
Fig. 6C shows that PP2A activity was strengthened in the
transfectants compared with the controls with or without the
differentiation treatment, but no such significant difference in total
phosphatase activity was seen between control and transfected cells
cultured with or without differentiation medium. Collectively, these
results suggest that the elevation of PP2A was responsible for
suppression of Akt phosphorylation in the gene-transfected cells,
leading to a greater susceptibility to apoptosis during differentiation.
PP2A Activity Is Related to the Regulation of Akt Activity in
Gene-transfected Cells--
To confirm that PP2A is involved in
the dephosphorylation and inactivation of Akt, we examined the effect
of a specific serine/threonine phosphatase inhibitor (calyculin A) on
the phosphorylation and activity of Akt in the gene transfectants
cultured in differentiation medium. The transfectants were cultured
with 1% FCS and RA for 24 h and then treated with 5 nM calyculin A for 0, 10, or 30 min. Fig.
7A shows that the specific
activity of PP2A was significantly reduced by the treatment with
calyculin A. In contrast, the phosphorylation and specific activity of
Akt were significantly increased by calyculin A in a
time-dependent manner (Fig. 7, B and
C). Taken together, these results suggest that the specific
activity of PP2A is closely related to the regulation of Akt function
in H9c2 cells.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 7.
Calyculin A suppresses PP2A activity, leading
to an increase in Akt phosphorylation and activity in gene-transfected
H9c2 cells upon differentiation treatment. A, effect of
calyculin A on PP2A activity in gene-transfected H9c2 cells upon
differentiation treatment. The transfectants were cultured with 1% FCS
and RA for 24 h and then treated with 5 nM calyculin A
for 0, 10, or 30 min. PP2A activity was assayed photometrically as
described under "Materials and Methods" using RKpTIRR as a
substrate. B, effect of calyculin A on Akt phosphorylation
in gene-transfected H9c2 cells upon differentiation treatment. The
transfectants were cultured with differentiation medium for 24 h
and then treated with calyculin as described for A.
Phosphorylated Akt and total Akt were detected by immunoblot analysis
as described under "Materials and Methods" using specific
antibodies. The phosphorylation rate of Akt is expressed as the
relative intensity of phosphorylated Akt (Akt-P)/Akt.
C, effect of calyculin A on Akt activity in gene-transfected
H9c2 cells upon differentiation treatment. The transfectants were
cultured with differentiation medium for 24 h and then treated
with calyculin as described for A. The activity of
immunoprecipitated Akt was measured as described under "Materials and
Methods" using GSK-3 / as a substrate. Phosphorylated
GSK-3 / was detected by immunoblot analysis, and the band
intensity was quantified densitometrically. Each value represents the
mean ± S.D. of three to four independent experiments.
|
|
Overexpression of CRT Increases the Intracellular Free Calcium
Concentration in H9c2 Cells--
CRT is a Ca2+ storage
protein in the ER that functions in intracellular calcium homeostasis
(1). We examined and compared the intracellular free Ca2+
contents of control and gene-transfected cells with or without the
differentiation treatment (Table I). In
the cells overexpressing CRT, the intracellular free Ca2+
concentration increased ~1.3-fold relative to the control value. This
increase seems to be different from previous reports (26, 27). After
24 h of treatment to induce differentiation, intracellular free
Ca2+ concentrations were up-regulated in both control and
gene-transfected cells compared with the initial levels; but the
concentration was always higher in the transfectants than in the
controls, indicating that it was continuously elevated in cells
overexpressing CRT.
View this table:
[in this window]
[in a new window]
|
Table I
Intracellular free calcium concentration in control and
gene-transfected H9c2 cells upon differentiation treatment
Each value represents the mean ± S.D. of six experiments.
|
|
Effect of Ca2+ Modulators on PP2Ac
Expression and
Akt Signaling--
To examine whether intracellular Ca2+
levels could affect expression of the PP2Ac
gene and change Akt
signaling, the effect of Ca2+ modulators on PP2Ac
expression and Akt signaling was investigated. To observe the effect of
increased intracellular Ca2+ levels, control cells were
treated with thapsigargin (5 µM) or ionomycin (1 µM) for specific periods, and the mRNA and protein expression levels of PP2Ac
were then estimated by Northern blot analysis and immunoblot analysis, respectively (Fig.
8, A and B,
left panels). Following the treatments, an increase in
intracellular free Ca2+ was observed using a
spectrofluorophotometer (data not shown). After 4 h of treatment
with thapsigargin or ionomycin, both the mRNA and protein levels of
PP2Ac
significantly increased, suggesting that PP2Ac
gene
expression is regulated by intracellular Ca2+ levels. To
confirm this, the CRT gene-transfected cells were treated with BAPTA/AM
(10 µM), a cell-permeable Ca2+ chelator, to
decrease intracellular Ca2+ levels, and the mRNA and
protein expression levels of PP2Ac
were then estimated as described
above (Fig. 8, A and B, right panels).
After 2 h of treatment with BAPTA/AM, both the mRNA and protein levels of PP2Ac
had significantly decreased. In parental H9c2 cells, BAPTA/AM showed a similar effect on PP2Ac
expression (data not shown). The protein levels of PP2B-A
showed no significant change upon treatment with such Ca2+ modulators. Together,
these results strongly suggest that PP2Ac
gene expression is
regulated via intracellular Ca2+ homeostasis. Next, to
clarify whether the change in PP2Ac
expression caused by
Ca2+ modulators reflects an alteration of Akt signaling,
the phosphorylation and activity of Akt were investigated. In control
cells treated with thapsigargin and ionomycin for 4 h, the
phosphorylation and activity of Akt were significantly suppressed (Fig.
8C, left panel). In contrast, the
gene-transfected cells treated with BAPTA/AM for 2 h showed an
increase in the phosphorylation and activity of Akt (Fig.
8C, right panel). In parental cells, BAPTA/AM had similar effects on Akt signaling (data not shown). The results for Akt
signaling were compatible with the change in PP2Ac
expression caused
by Ca2+ modulators. Collectively, these results indicate
that PP2Ac
expression is regulated via intracellular
Ca2+ homeostasis, leading to the alteration of Akt
signaling, suggesting that the change in PP2Ac
expression and Akt
signaling in CRT-overexpressing cells is mainly due to the altered
regulation of intracellular Ca2+ levels.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of Ca2+ modulators on
PP2Ac expression and Akt signaling.
Control H9c2 cells were treated with thapsigargin (5 µM)
or ionomycin (1 µM) for the periods indicated (left
panels). The CRT gene-transfected cells were treated with BAPTA/AM
(10 µM) for the periods specified (right
panels). After each treatment, cells were harvested and subjected
to the following assays. A, shown are the results from
Northern blot analysis of PP2Ac . Total RNA (10 µg) was separated
by electrophoresis and then blotted onto nylon membrane. The membrane
filter was hybridized with 32P-labeled DNA probes for
PP2Ac . Autoradiographed membranes were analyzed using a Fuji BAS5000
bioimage analyzer. B, shown are the results from immunoblot
(IB) analysis of PP2Ac and PP2B-A . The protein
expression levels for PP2Ac and PP2B-A were estimated by
immunoblot analysis using specific antibodies. C,
phosphorylated Akt (Akt-P) and total Akt were detected by
immunoblot analysis using specific antibodies as described under
"Materials and Methods." Akt activity was assayed as described under "Materials and Methods" using GSK-3 / as a
substrate. The enzymatic product of Akt, phosphorylated GSK-3 /
(GSK-3 / -P), was detected by immunoblot analysis using
anti-phosphorylated GSK-3 / antibody. The data represent three
independent experiments.
|
|
 |
DISCUSSION |
In this study, we employed cardiomyoblast H9c2 cells to
establish a cell line overexpressing CRT and then examined the effect of the overexpression on the cardiac differentiation of H9c2 cells. When cultured in a differentiation medium containing 1% FCS and 10 nM RA, the overexpressers showed a decrease in cell number and an increase in DNA double-strand breaks, indicating that they were
highly susceptible to apoptosis compared with controls. We found
that Akt signaling was significantly suppressed in the gene-transfected cells compared with the mock-transfected controls during
differentiation. In control cells, the phosphorylation and activity of
Akt showed a gradual decline during the culture. In contrast, the
decline was significantly accelerated in the gene-transfected cells.
Furthermore, in the transfectants, PP2A, a Ser/Thr protein phosphatase,
was significantly up-regulated in response to the treatment, implying that suppression of Akt signaling was due to dephosphorylation of Akt
caused by the up-regulated PP2A expression. Consequently, we conclude
that overexpression of CRT promotes the
differentiation-dependent apoptosis of H9c2 cells through
suppression of the Akt signaling pathway via up-regulation of PP2A by
altered Ca2+ homeostasis. This is the first report of the
Akt-mediated cell survival signaling pathway being modulated by the
introduction of the CRT gene.
Apoptosis is regulated by several signaling pathways, including
the SAPK, MAPK, and protein kinase B/Akt pathways (24). The Akt
signaling pathway is a well characterized anti-apoptotic signal
for cell survival (28). Under conditions in which the PI3K/Akt pathway
was suppressed by PI3K inhibitors, differentiation-induced apoptosis
was significantly enhanced, and Akt phosphorylation was diminished in
both control and CRT gene-transfected cells (Fig. 5). This indicates
that Akt is an important cell survival and anti-apoptotic signal in
differentiating H9c2 cells. To elucidate why Akt signaling was affected
by overexpression of CRT, we compared the activity of PI3K, an upstream
signal of Akt, between control and transfected cells. Surprisingly,
there was no significant difference in the activity of PI3K between the
cells, although differentiation-induced apoptosis was promoted in both
cases by PI3K inhibitors (data not shown). In general, growth
factor-induced activation of Akt is mediated by PI3K (28), but
PI3K-independent activation of Akt was also reported to occur in
response to specific stresses such as heat shock and hyperosmolarity
(29). Therefore, in the case of H9c2 cells undergoing differentiation,
Akt signaling might not be regulated solely by PI3K. Previously, PI3K
and Akt signals were both reported to be involved in the skeletal
differentiation of H9c2 cells (30). The authors described that PI3K
regulated cell differentiation mainly through an Akt-independent
pathway. However, to our knowledge, there is no report that Akt
functions in the apoptosis of H9c2 cells.
To identify other regulators of Akt activity and signaling, we focused
on protein phosphatases that could regulate the activity by
dephosphorylating phosphoseryl or phosphothreonyl residues of Akt. We
found that the expression and activity of PP2A were significantly
increased in the gene transfectants compared with the controls
throughout the differentiation (Fig. 6). Ser/Thr-specific PP2A is
present in most eukaryotic cells and functions in a variety of
processes, including cell cycle regulation, cell differentiation, and
signal transduction (31-33). PP2A is known to modulate the activities
of several kinases in vitro and in vivo such as
phosphorylase kinase (34), MAPKs, the calmodulin-dependent
kinase, protein kinase A, protein kinase B/Akt, protein kinase C, p70
S6 kinase, I
B kinase, and cyclin-dependent
kinases (35). Akt is inactivated in vitro by PP2A and is
activated in cells upon treatment with okadaic acid (36-38) and
calyculin A (37, 39), suggesting that Akt is a putative substrate for
PP2A. We also observed that calyculin A inhibited PP2A activity to
prevent the differentiation-induced dephosphorylation and inactivation
of Akt in cells transfected with the CRT gene (Fig. 7). Collectively,
these results strongly suggest that PP2A acted as a regulator for
dephosphorylation and inactivation of Akt in the transfected H9c2 cells
during their differentiation.
Recently, it was reported that CRT expression levels can modulate
intracellular signaling, including the
-catenin pathway, by altering
protein-tyrosine kinase or phosphatases (40). It was observed that
overexpression of CRT in mouse L fibroblasts decreased protein
phosphorylation at tyrosine and also that the dephosphorylated protein
was
-catenin, although the mechanism of the
CRT-dependent modulation of tyrosine dephosphorylation was
not made clear. Similarly, in H9c2 cells overexpressing CRT, we too
observed a decrease in protein phosphorylation at tyrosine compared
with controls (data not shown). However, it is worth nothing that the
phosphotyrosine levels and patterns for PI3K-associated proteins
differed little between the control and gene-transfected cells (data
not shown). PI3K is activated by binding through Src homology domain 2 to signaling proteins bearing phosphotyrosine (41). These findings
suggest that the decrease in protein phosphorylation at tyrosine occurs
selectively in cells overexpressing CRT, although the molecular
mechanism involved is not known.
Recently, Nakamura et al. (42) reported that cells
deficient in CRT are resistant to apoptosis compared with cells
expressing CRT. Pinton et al. (43) have also shown
that overexpression of CRT promotes ceramide-induced apoptosis in HeLa
cells. These results seem to support our finding that CRT expression
positively regulates the apoptotic process under specific cellular
conditions such as during cell differentiation. However,
Oyadomari et al. (44) reported that overexpression
of CRT actually protects pancreatic
-cells from nitric oxide-induced
apoptosis, whereas Zhu and Wang (45) found that CRT antisense
oligonucleotides down-regulate CRT protein production and
significantly increase the sensitivity to calcium ionophore-induced
apoptosis. This discrepancy may be due to the different cell types,
stress stimuli, and experimental models used, but further investigation
is needed into the molecular mechanism of the apoptotic process in each
of these experimental models.
Retinoids are potent regulators of cell proliferation and
differentiation (46). CRT was reported to interfere with retinoid signals both in vitro and in vivo (47-50). Very
recently, Holaska et al. (5) demonstrated that some CRT
exists in the cytosol, where it functions as a nuclear export receptor
for the glucocorticoid receptor by binding its DNA-binding domain,
including the sequence KGFFKR. They suggested that retinoid receptors
are also regulated by this nuclear export pathway because they contain
an amino acid sequence highly similar to that of the glucocorticoid
receptor. In the present study, RA was used to induce the cardiac
differentiation of H9c2 cells. However, H9c2 cells are known to
differentiate into skeletal myotubes in culture medium containing 1%
FCS and no RA (14, 30). Similarly, in the CRT gene transfectants, differentiation-induced apoptosis was observed only when 1% FCS was present in the culture medium (data not shown). Moreover, Akt
signaling was suppressed accompanying the up-regulation of PP2A in the
transfectants only with 1% FCS (data not shown). Thus, these findings
suggest that the differentiation-induced apoptosis promoted in the
cells overexpressing CRT is not solely due to the alteration of
retinoic acid signaling. In a previous report, the selective
down-regulation of the catalytic
-subunit (but not
-subunit) of
PP2A was observed during RA-induced differentiation of HL-60 cells
(51), but the biological significance and molecular mechanism of this
event are still not known.
A previous study indicates that enhanced expression of CRT increases
the Ca2+ storage capacity of the ER (1). CRT also appears
to modulate store-operated Ca2+ influx (26, 27, 52, 53) and
to alter Ca2+ transport by the sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase SERCA2b (54). In the present study,
the intracellular free concentration Ca2+ was higher in the
CRT gene transfectants than in the controls throughout differentiation.
To elucidate whether altered Ca2+ homeostasis could affect
PP2Ac
expression and Akt signaling, the effect of Ca2+
modulators on PP2Ac
expression and Akt signaling was tested (Fig.
8). The results showed that PP2Ac
expression increased to suppress
Akt signaling upon treatment with thapsigargin and ionomycin, which
increased the level of intracellular Ca2+. Furthermore,
upon treatment with BAPTA/AM, which decreases intracellular Ca2+ levels, PP2Ac
expression decreased to enhance Akt
signaling. These results strongly suggest that PP2Ac
gene expression
is controlled by intracellular Ca2+ levels and homeostasis.
The gene structure and regulation of PP2A have been elucidated in human
and rat. In both PP2Ac
genes, the promoter region is GC-rich and
lacks TATA and CCAAT sequences, consistent with a housekeeping gene
(55, 56). The PP2Ac
gene contains several Sp1-binding sites and a
potential cAMP-responsive element (CRE). CRE may be regulated by a
calcium-regulated transcription factor (CRE-binding protein) through
Ca2+/calmodulin-dependent kinases (57), but the
DNA-binding activity for CRE was suppressed in the CRT gene-transfected
cells compared with control cells in the electrophoretic mobility shift
assay (data not shown). Rather, the DNA-binding activity for Sp1
increased in the CRT gene-transfected cells compared with control
cells (data not shown). Although the precise mechanism linking CRE, Sp1, and overexpression of CRT in H9c2 cells is still not clear, further investigation based on Ca2+ homeostasis will be
required to understand the gene regulation by overexpression of CRT.
Although elevations in Ca2+ act as a signal, a prolonged
increase in the concentration of Ca2+ can be lethal (58).
Moreover, transcription factors are activated differentially by the
amplitude and duration of the response to Ca2+ (59).
Therefore, overexpression of CRT may affect the transcriptional regulation of PP2Ac
mainly via the regulation of
Ca2+ homeostasis in H9c2 cells.
CRT functions as a molecular chaperone in the ER (60). It is widely
believed that CRT and its membrane-bound homolog calnexin act as
molecular chaperones for N-linked glycoproteins because they
are associated predominantly with folding intermediates rather than
fully folded glycoproteins in vivo (60, 61). It has also been confirmed that CRT and calnexin function as chaperones for both
glycosylated and non-glycosylated proteins in vitro (62, 63)
and in vivo (64). This chaperone function of CRT may also contribute to the differentiation-induced apoptosis of H9c2 cells overexpressing CRT by affecting the ER stress signaling pathway. When
the ER is under stress, resident kinases such as IRE1 and PKR-like ER kinase are activated to produce stress signals through a
change in the luminal environment, e.g. by accumulation of
unfolded proteins in the ER (65). Another ER chaperone, BiP, has been reported to be involved in the regulation of IRE1 activation in the ER
under stress conditions (66). Moreover, Urano et al. (67)
demonstrated that IRE1 activates c-Jun N-terminal kinase in response to
ER stress. This strongly suggests that endogenous signals initiated in
the ER modulate cytoplasmic signal transduction cascades. Recently,
Nakagawa et al. (68) reported that caspase-12 is activated
in the ER specifically in response to ER stress. Therefore, it is also
possible that a pathway containing caspase-12 is involved in the
differentiation-induced apoptosis of H9c2 cells overexpressing CRT.
In conclusion, we have demonstrated that, when overexpressed, CRT
modulates Akt signaling to promote differentiation-induced apoptosis in
H9c2 cells. CRT is essential for cardiac development, and its
expression is strictly down-regulated in mature cardiomyocytes. As CRT
functions to promote apoptosis, it may have some important physiological function in the process of cardiogenesis. Although further investigation of the correlation between CRT expression and
apoptotic signals is required, this study has revealed a novel pathway
of cellular signaling for apoptosis and its regulation via a change in
the ER luminal environment and Ca2+ homeostasis.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Kunimi Kikuchi and
Hiroshi Shima for generously providing the rat PP1
c and PP2Ac
cDNAs. We also thank Noriko Sadakata, Satoko Mori, and
Hiromi Setoguchi for technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by grants-in-aid from the
Ministry of Education, Science, Sports, and Culture of Japan and by the
Japan Foundation of Cardiovascular Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Both authors contributed equally to this work.
To whom correspondence should be addressed. Tel.:
81-95-849-7099; Fax: 81-95-849-7100; E-mail:
y-ihara@net.nagasaki-u.ac.jp.
Published, JBC Papers in Press, March 20, 2002, DOI 10.1074/jbc.M112377200
 |
ABBREVIATIONS |
The abbreviations used are:
CRT, calreticulin;
ER, endoplasmic reticulum;
PP, protein phosphatase;
DMEM, Dulbecco's
modified Eagle's medium;
FCS, fetal calf serum;
RA, all-trans-retinoic acid;
PBS, phosphate-buffered saline;
TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end
labeling;
GSK, glycogen synthase kinase;
SAPK, stress-activated
protein kinase;
MAPK, mitogen-activated protein kinase;
PI3K, phosphatidylinositol 3-kinase;
BAPTA/AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid tetra(acetoxymethyl) ester;
CRE, cAMP-responsive
element.
 |
REFERENCES |
| 1.
|
Michalak, M.,
Corbett, E. F.,
Mesaeli, N.,
Nakamura, K.,
and Opas, M.
(1999)
Biochem. J.
344,
281-292[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Michalak, M.,
Milner, R. E.,
Burns, K.,
and Opas, M.
(1992)
Biochem. J.
285,
681-692[Medline]
[Order article via Infotrieve]
|
| 3.
|
Johnson, S.,
Michalak, M.,
Opas, M.,
and Eggleton, P.
(2001)
Trends Cell Biol.
11,
122-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Krause, K.-H.,
and Michalak, M.
(1997)
Cell
88,
439-443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Holaska, J. M.,
Black, B. E.,
Love, D. C.,
Hanover, J. A.,
Leszyk, J.,
and Paschal, B. M.
(2001)
J. Cell Biol.
152,
127-140[Abstract/Free Full Text]
|
| 6.
|
Imanaka-Yoshida, K.,
Amitani, A.,
Ioshii, S. O.,
Koyabu, S.,
Yamakado, T.,
and Yoshida, T.
(1996)
J. Mol. Cell. Cardiol.
28,
553-562[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Srivastava, D.,
and Olson, E. N.
(2000)
Nature
407,
221-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Guo, L.,
Lynch, J.,
Nakamura, K.,
Fliegel, L.,
Kasahara, H.,
Izumo, S.,
Komuro, I.,
Agellon, L. B.,
and Michalak, M.
(2001)
J. Biol. Chem.
276,
2797-2801[Abstract/Free Full Text]
|
| 9.
|
Mesaeli, N.,
Nakamura, K.,
Zvaritch, E.,
Dickie, P.,
Dziak, E.,
Krause, K.-H.,
Opas, M.,
MacLennan, D. H.,
and Michalak, M.
(1999)
J. Cell Biol.
144,
857-868[Abstract/Free Full Text]
|
| 10.
|
Rauch, F.,
Prud'homme, J.,
Arabian, A.,
Dedhar, S.,
and St-Arnaud, R.
(2000)
Exp. Cell Res.
256,
105-111[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Nakamura, K.,
Robertson, M.,
Liu, G.,
Dickie, P.,
Nakamura, K.,
Guo, J. Q.,
Duff, H. J.,
Opas, M.,
Kavanagh, K.,
and Michalak, M.
(2001)
J. Clin. Invest.
107,
1245-1253[Medline]
[Order article via Infotrieve]
|
| 12.
|
Kimes, B. W.,
and Brandt, B. L.
(1976)
Exp. Cell Res.
98,
367-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hescheler, J.,
Meyer, R.,
Plant, S.,
Krautwurst, D.,
Rosenthal, W.,
and Schultz, G.
(1991)
Circ. Res.
69,
1476-1486[Abstract/Free Full Text]
|
| 14.
|
Ménard, C.,
Pupier, S.,
Mornet, D.,
Kitzmann, M.,
Nargeot, J.,
and Lory, P.
(1999)
J. Biol. Chem.
274,
29063-29070[Abstract/Free Full Text]
|
| 15.
|
Smith, M. J.,
and Koch, G. L.
(1989)
EMBO J.
8,
3581-3586[Medline]
[Order article via Infotrieve]
|
| 16.
|
Gavrieli, Y.,
Sherman, Y.,
and Benn-Sasson, S. A.
(1992)
J. Cell Biol.
119,
493-501[Abstract/Free Full Text]
|
| 17.
|
Nicoletti, I.,
Migliorati, G.,
Pagliacci, M. C.,
Gringnani, F.,
and Riccardi, C.
(1991)
J. Immunol. Methods
139,
271-279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Ihara, Y.,
Sakamoto, Y.,
Mihara, M.,
Shimizu, K.,
and Taniguchi, N.
(1997)
J. Biol. Chem.
272,
9629-9634[Abstract/Free Full Text]
|
| 19.
|
Kitamura, K.,
Mizuno, Y.,
Sasaki, A.,
Yasui, A.,
Tsuiki, S.,
and Kikuchi, K.
(1991)
J. Biochem. (Tokyo)
109,
307-310[Abstract/Free Full Text]
|
| 20.
|
Kitagawa, Y.,
Tahira, T.,
Ikeda, I.,
Kikuchi, K.,
Tsuiki, S.,
Sugimura, T.,
and Nagao, M.
(1988)
Biochim. Biophys. Acta
951,
123-129[Medline]
[Order article via Infotrieve]
|
| 21.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, pp. 7-39, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 22.
|
Chen, Q.,
Jones, T. W.,
and Stevens, J. L.
(1994)
J. Cell. Physiol.
161,
293-302[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Grynkiewcz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 24.
|
Ballif, B. A.,
and Blenis, J.
(2001)
Cell Growth Differ.
12,
397-408[Free Full Text]
|
| 25.
|
Alessi, D. R.,
Andjelkovic, M.,
Caudwell, B.,
Cron, P.,
Morrice, N.,
Cohen, P.,
and Hemmings, B. A.
(1996)
EMBO J.
15,
6541-6551[Medline]
[Order article via Infotrieve]
|
| 26.
|
Bastianutto, C.,
Clementi, E.,
Codazzi, F.,
Podini, P., De,
Giorgi, F.,
Rizzuto, R.,
Meldolesi, J.,
and Pozzan, T.
(1995)
J. Cell Biol.
130,
847-855[Abstract/Free Full Text]
|
| 27.
|
Mery, L.,
Mesaeli, N.,
Michalak, M.,
Opas, M.,
Lew, D. P.,
and Krause, K.-H.
(1996)
J. Biol. Chem.
271,
9332-9339[Abstract/Free Full Text]
|
| 28.
|
Coffer, P. J.,
Jin, J.,
and Woodgett, J. R.
(1998)
Biochem. J.
335,
1-13[Medline]
[Order article via Infotrieve]
|
| 29.
|
Konishi, H.,
Matsuzaki, H.,
Tanaka, M.,
Ono, Y.,
Tokunaga, C.,
Kuroda, S.,
and Kikkawa, U.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7639-7643[Abstract/Free Full Text]
|
| 30.
|
Kim, J. M.,
Yoon, M.-Y.,
Kim, J.,
Kim, S. S.,
Kang, I., Ha, J.,
and Kim, S. S.
(1999)
Arch. Biochem. Biophys.
367,
67-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Mumby, M. C.,
and Walter, G.
(1993)
Physiol. Rev.
73,
673-699[Abstract/Free Full Text]
|
| 32.
|
Mayer-Jaekel, R. E.,
and Hemmings, B. A.
(1994)
Trends Cell Biol.
4,
287-291[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Janssens, V.,
and Goris, J.
(2001)
Biochem. J.
353,
417-439[CrossRef][Medline]
[Order arti |